loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Cobicistat

    Menu

    Cobicistat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206353 / DOSAGE - TABLET;ORAL - EQ 300MG BASE;150MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATAZANAVIR SULFATE(UNII: 4MT4VIE29P)
    (ATAZANAVIR - UNII:QZU4H47A3S)     		ATAZANAVIR300mg
    COBICISTAT(UNII: LW2E03M5PG)
    (COBICISTAT - UNII:LW2E03M5PG)     		COBICISTAT150mg

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
    CROSPOVIDONE(68401960MK)
    HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
    HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
    STEARIC ACID(4ELV7Z65AP)